Search clinical trials for: Hylenex, time tagged pain pain reduction, hospice population

Total 60755 results

Samuel Lunenfeld Research Institute, Mount Sinai...

Completed

Ideal Dose of Phenylephrine to Treat Low Blood Pressure During Cesarean Section

Nausea | Hypotension

Canada
Albany Medical College

Suspended

Effect of Garlic on Inflammatory Mediators

Healthy

United States
Bayside Health
Deakin University

Completed

Time Interval for Changing Closed System Suction Catheters, Effect on Ventilator Associated Pneumonia

Pneumonia, Ventilator Associated | Closed System Suction Catheter

Australia
Baxter Healthcare Corporation

Completed

A Crossover Study Assessing the Pharmacokinetics, Pharmacodynamics, and Safety of Recombinant Human Insulin

Healthy

Germany
Eli Lilly and Company

Completed

Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature

Growth Disorder

United States
Eli Lilly and Company

Completed

Effects of Arzoxifene on Bone Mass and the Uterus

Postmenopausal Bone Loss

United States
Charles University, Czech Republic

Completed

Glucose Control by eMPC Algorithm in Peri- and Postoperative Period in Cardiac Surgery Patients

Cardiac Surgery Patients | Blood Glucose

Czech Republic
Eli Lilly and Company

Completed

Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents

Attention Deficit Hyperactivity Disorder

United Kingdom
HaEmek Medical Center, Israel
Clalit Health Services

Withdrawn

Nitrofurantoin Macrocrystals 3 Days Versus 7 Days in the Treatment of Women With Uncomplicated Cystitis

Cystitis

Israel
Eli Lilly and Company

Completed

Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder

Social Phobia

United States
Dallas VA Medical Center
Centocor, Inc.

Unknown

Cardiovascular Outcomes in the VA's Rheumatoid Arthritis(VARA) Population

Coronary Disease | Cardiovascular Disease | Rheumatoid Arthritis

United States
Eli Lilly and Company

Completed

Bone Effects of Teriparatide Following Alendronate

Osteoporosis

Austria, Czech Republic
Eli Lilly and Company

Completed

Raloxifene Use for The Heart

Cardiovascular Diseases | Breast Neoplasms

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine in the Treatment of Stress Urinary Incontinence.

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

Urinary Incontinence, Stress

France, Sweden, Netherlands, Spain, Germany, South Africa, Switzerland
Eli Lilly and Company

Completed

A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.

Genital Neoplasms, Female | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Pelvic Neoplasms

United States
Eli Lilly and Company

Completed

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

Depression, Bipolar

United States, Puerto Rico
Eli Lilly and Company

Completed

A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer

Breast Neoplasms

United States
Eli Lilly and Company

Completed

An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Germany
Eli Lilly and Company

Completed

An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Germany
Eli Lilly and Company

Completed

A Study of LY317615 in Patients With Brain Tumors

Malignant Glioma

United States
Eli Lilly and Company

Completed

A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer

Breast Cancer

Canada
Eli Lilly and Company

Completed

Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

Bipolar Disorder

Hungary, Australia, Greece, Russian Federation
Eli Lilly and Company

Completed

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company

Completed

Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.

Attention Deficit Hyperactivity Disorder

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company

Completed

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

Gastrointestinal Neoplasms

Korea, Republic of
Eli Lilly and Company

Completed

Teriparatide Use in Hip Replaced Subjects

Osteoporosis

Italy
Eli Lilly and Company

Completed

A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

Carcinoma, Small Cell

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

United States, Canada
Eli Lilly and Company

Completed

A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma

Advanced Gastric Carcinoma

Italy
Eli Lilly and Company

Completed

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Mesothelioma

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.

Urinary Incontinence, Stress

United States, Canada, United Kingdom
Eli Lilly and Company

Completed

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small Cell Lung

China, Taiwan, Australia, Korea, Republic of, Egypt, Romania, India, Turkey
Eli Lilly and Company

Completed

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

Mesothelioma

United States
Eli Lilly and Company

Completed

Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

Urinary Stress Incontinence

United States, Slovenia, United Kingdom
Eli Lilly and Company

Completed

Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung

United States
Eli Lilly and Company

Completed

Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer

Breast Cancer | Neoplasm Metastasis

Russian Federation
Eli Lilly and Company

Completed

Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company

Completed

Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Lung Neoplasms

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence

Urinary Stress Incontinence

United States, Netherlands
Eli Lilly and Company

Completed

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Bipolar Disorder

United States, Lithuania, Puerto Rico, Romania, Russian Federation
Eli Lilly and Company

Completed

Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer.

Non-Small-Cell Lung Carcinoma

Argentina, Brazil, Chile, Mexico
Eli Lilly and Company

Completed

A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company

Completed

A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)

Sepsis

Germany
Eli Lilly and Company

Completed

A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer

Pancreatic Cancer

United States
Eli Lilly and Company

Completed

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

Adenocarcinoma

Canada
Eli Lilly and Company

Completed

A Study in People With Abnormal Fat Levels in the Blood

Dyslipidemia

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Urinary Incontinence, Stress

Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Urinary Incontinence Stress

United Kingdom

Search clinical trials for: Hylenex, time tagged pain pain reduction, hospice population

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations